GI
BMY icon

GLG Inc’s Bristol-Myers Squibb BMY Stock Holding History

GLG Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$8.24M Sell
155,134
-889
-0.6% -$45.3K 0.22% 134
2013
Q3 		$7.22M Hold
156,023
– – 0.14% 194
2013
Q2 		$6.97M Buy
+156,023
New +$6.77M 0.17% 121

Other funds holding BMY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLG Inc's BMY Position: Q4 2013 in Review

GLG Inc reduced its Bristol-Myers Squibb (BMY) stake by 0.57% in Q4 2013, selling an estimated $45.3K and leaving 155,134 shares worth $8.24M. The position accounts for 0.22% of the portfolio, ranked #134.

GLG Inc first reported a position in BMY in Q2 2013 and has held it in 3 quarters since. 1,312 funds tracked by Wall St. Rank hold BMY as of Q4 2013.

  • GLG Inc held 155,134 shares of Bristol-Myers Squibb worth $8.24M as of Q4 2013.
  • GLG Inc sold 889 Bristol-Myers Squibb shares in Q4 2013, an estimated $45.3K.
  • Bristol-Myers Squibb made up 0.22% of GLG Inc's portfolio in Q4 2013, its #134 holding.
  • GLG Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 3 quarters since.
  • 1,312 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.